During these last 30 years there have been many advances in the field of hereditary red blood cells diseases (HRBD) and hemoglobinopathies research. We now know more about how the globin genes are regulated and expressed during growth and development including how the mutations in the globin genes affect ...
During these last 30 years there have been many advances in the field of hereditary red blood cells diseases (HRBD) and hemoglobinopathies research. We now know more about how the globin genes are regulated and expressed during growth and development including how the mutations in the globin genes affect their expression. New method of hemoglobin analyses and molecular detection have been developed. We know more of the natural history of HRBD with various pathophysiological changes. All of these lead to better quality of life of patients worldwide. In the meantime, there is also progress in the prevention and control of HRBD around the world.
We would like to address the following:
- To develop a rapid method for preventive diagnosis of HRDB.
- Technology transfer of our innovative research to all national university hospital centers to be easily accessible to the patient and the clinician.
- Citizen empowerment towards HRDB.
- Improving the level of health literacy through innovative educational devices.
Keywords:
sickle cell anemia, thalassemia, eryptosis, plasmatic microvisicles, perceptions
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.